1. Sialic acid moieties of erythrocyte membrane glycoproteins are the principal determinants of the negative charge on the cell surface. The resultant electrostatic repulsion between the cells reduces erythrocyte aggregation and hence the low shear rate viscosity and yield stress of blood. 2. Using g.c.-m.s., a decrease in sialic acid content has been observed in the major erythrocyte membrane glycoprotein, glycophorin A, obtained from nine diabetic patients compared with that from seven normal control subjects [median (range): 3.30 (0.01-1 1.90) versus 18.60 (3.20-32.60) pg/lOO pg of protein, P < 0.021. 3. Erythrocyte aggregation, measured by viscometry as the ratio of suspension viscosity to supernatant viscosity (LJS) in fibrinogen solution, was increased in ten diabetic patients compared with ten normal control subjects ( m e a n f s m , 37.6 k 1.3 versus 33.8 k0.6, 4. In the patients in whom both viscometry and carbohydrate analysis were performed, the decrease in erythrocyte glycophorin sialylation and the increase in erythrocyte aggregation in fibrinogen solution were related statistically(L,/S correlated negatively with glycophorin sialic acid content, r = 0.73, P < 0.05). 5. Decreased glycophorin sialylation provides an explanation at the molecular level for increased erythrocyte aggregation and it may be important in the pathogenesis of vascular disease in diabetes.
INTRODUCTION
Glycosylation of proteins alters their properties and may cause a change in their electrical charge. Glycosylated membrane proteins are determinants of the negative charge on cell membranes, and the heavily charged sialic acid moieties have particular importance. In the erythrocyte membrane, the glycophorins are sialylated glycoproteins responsible for much of the negative charge normally found on the membrane surface [l, 21 . This negative charge has haemorheological and haemodynamic significance, since it is found that the removal of membrane sialic acid by neuraminidase, and the consequent diminution of the normal intercellular electrostatic repulsion, leads to enhanced erythrocyte aggregation [ 31 or rouleaux formation. This in turn leads to an elevation of the low shear rate viscosity [4] and yield stress [5] of blood. There is also evidence indicating that a reduction in sialic acid levels increases the erythrocytic interaction with the vascular endothelium [6] , again due to reduced electrostatic effects.
In diabetes, a decrease in membrane surface charge is observed in a variety of tissues including erythrocytes [7- 101. The surface charge of the glomerular basement membrane is decreased in animal models, and this is associated with albuminuria [ll, 121. In human diabetes, a decrease in erythrocyte negative charge has been observed [lo] . Decreased erythrocyte membrane sialic acid content has been proposed from colorimetric [ 131 and from affinity cytochemical [14] studies, although no decrease was observed using an enzymic assay [lo] .
Haemorheological abnormalities are found in the blood from diabetic patients [ 151, the most consistent of which are enhanced erythrocyte aggregation and low shear rate viscosity. Although there is generally an elevated level of the rouleaugenic protein, fibrinogen, in these subjects [16] , this does not fully account for the increased erythrocyte aggregation observed [ 171. Erythrocytes from diabetic patients have a greater tendency also to adhere to the vascular endothelium than those from normal subjects [6, 181 . A possible cause of these abnormalities is the decrease in sialic acid and the associated decrease in membrane charge.
We have investigated, in diabetic patients and control subjects, the sialic acid content of the major specific erythrocyte membrane glycoprotein, glycophorin A, using g.c.-m.s. for the carbohydrate analysis. Glycophorin sialylation was related to the viscometric properties of the erythrocytes suspended in solutions of fibrinogen or dextran [ 191 used as standard erythrocyte-aggregating suspending phases.
METHODS

Subjects
Blood samples were obtained from nine diabetic patients (five male, four female; aged 25-59 years). Details of the patients are provided in Table 1 . The duration of diabetes ranged from 1 to 30 years. The five patients with non-insulin-dependent diabetes (NIDDM) were treated with diet alone (two patients), diet plus glibenclamide and metformin therapy (two patients) and diet plus chlorpropamide and metformin therapy (one patient). The patients with insulin-dependent diabetes (IDDM) were treated with either a combination of shortand intermediate-acting insulins or intermediate-acting insulin alone. For comparison, blood samples were also obtained from seven normal control subjects without any known disease and on no medications (five male, two female; age 23-47 years).
Glycophorin carbohydrate monosaccharide content was measured by g.c.-m.s. Erythrocyte ghosts were prepared after the addition of venous blood from diabetic patients or control subjects (22.5 ml) to 2.5 ml of 0.109 mol/l trisodium citrate maintained at 4°C. After centrifugation at 4000 g for 15 min, the plasma and buffy coat were removed and the cells were washed three times with 0.15 mol/l NaCl and four times with 20 ml 0.103 mol/l Na,HPO, adjusted to pH 7.4 with 0.155 mol/l NaH,PO, (stock buffer). The cells were lysed in 200 ml of cold 5 mmol/l phosphate buffer (1:20 dilution of stock) and the ghosts were collected by centrifugation at 20 000 g for 40 min. The ghosts were washed in 5 mmol/l phosphate buffer containing 2 mmol/l phenylmethanesulphonyl fluoride (a protease inhibitor). After re-suspension in 50 ml of 20 mmol/l phosphate buffer (15 dilution of stock), pH 7.4, the ghosts were centrifuged at 20000 g for 40 rnin at 4°C and the resultant pellet was re-suspended in 10 ml of the same buffer. Butanol extraction was begun by adding 4.5 ml of ice-cold n-butanol followed by vigorous shaking for 30 s. The suspension was kept on ice for 15 min, and then centrifuged at 40000 g for 15 min, the aqueous phase removed and a further 5 ml of 20 mmol/l phosphate buffer was added to the n-butanol phase and interface material. The extraction was performed and both aqueous phases were pooled. These were dialysed overnight against 4 litres of 0.1 mmol/l phosphate buffer Table I . Clinical information, erythrocyte glycophorin carbohydrate analysis and viscometry in diabetic patients and in normal control subjects. N-Acetylgalactosamine was not assayed in patient no. I and viscometry was not performed in patient no. 2 because of technical error. Viscometry alone was performed in patient nos. 5 and I I and in control subject nos. 8 ( 1 : l O O O dilution of stock), pH 7.4 containing 0.15 mol/l NaCI, and then freeze-dried. The freeze-dried extract was re-dissolved in 500 pl of distilled water and was applied to a Sepharose 6B (90 cm x 2.5 cm) column, previously equilibrated with 0.2 mmol/l NaCl containing 50 mmol/l Tris HCl (pH 8.0) and 0.1 mmol/l EDTA. The fractions collected were assayed for protein by the technique of Bradford [20] and the elution profile showed two welldefined peaks (Fig. la) . Fractions from the second peak were shown on SDS/PAGE to consist predominantly of material with the same mobility as glycophorin A (approximately 95%). SDS/PAGE was performed on a 12% (w/v) gel with a 6% (w/v) stacking gel and run at 30 mA [21] . Glycoprotein (4 pg) from each peak was run, together with M, markers, and stained using a periodic acid method adapted for silver staining. Fig. l ( b ) shows the strip from diabetic patient no. 6. Aggregated glycophorin migrated as a band of M, approximately 80000.
Fractions from the second chromatographic peak were therefore pooled for each subject and were used for carbohydrate analysis. The pooled fractions were freezedried, re-dissolved in 5 ml of distilled water, dialysed overnight against water and freeze-dried again. They were re-dissolved in 3 ml of water, separated into three 1 ml aliquots and freeze-dried. One sample was utilized for the final protein estimation [mean of six readings, standardized using Sigma glycophorin (G95 1 l)]. A further sample was used for carbohydrate analysis by g.c.-m.s. The sample was dissolved in water to achieve a protein concentration of 1 pg/pl. myo-Inositol (50 pl, 10 mg/l) was added to 100 pg of protein in solution, as an internal standard, and freeze-dried. Methanolysis was performed by heating at 80°C for 2 h with 200 pl of a mixture of 0.178 ml of acetyl chloride and 4.822 ml of methanol. After drying under nitrogen, this was followed by re-Nacetylation with 200 pl of acetic anhydride/methanol (1:4, v/v). Trimethylsilylation was achieved with 100 pl of TRI-SIL (Pierce no. 48999) at 50°C for 15 min. Derivatized monosaccharides were dissolved in hexane and the samples were analysed by g.c.-m.s using a 5890 Hewlett-Packard gas chromatograph (DB-5 capillary column; Chrompak) and a VG 40-250 mass spectrometer.
Erythrocyte aggregation was determined as the ratio of suspension viscosity to supernatant viscosity ( L J S ) in solutions of fibrinogen and dextran. A 5 ml sample of citrated blood was centrifuged and the plasma and buffy coat of leucocytes and platelets were removed. The erythrocytes were then washed in phosphate-buffered saline (PBS; 5.7 mmol/l KH,PO,, 24.3 mmol/l Na,HPO,, 121.1 mmol/l NaCl and finally were suspended in PBS at a packed cell volume of 45%, measured on a Hawksley Microhaematocrit centrifuge. This suspension was divided into two portions which were centrifuged again. A small volume of supernatant was then removed from each and was replaced with an equal volume of either a solution of Dextran 70 (Pharmacia) or of fibrinogen (Kabi), both of which had been extensively dialysed against PBS. The result was that the cells were still present at a packed cell volume of 45%, but were now suspended
Fraction no. (a) , and SDSlPAGE of glycophorin (6). In (a) the elution profile from diabetic patient no. 6 is illustrated. In ( b ) glycoprotein from patient no. 6 is illustrated, together with M, markers, stained with periodic acid adapted for silver staining.
in PBS containing either dextran or fibrinogen at a concentration in the suspending phase of 25 or 7 g/l, respectively. The cells were resuspended and the viscosities of the suspensions were measured at high (128.5 s-I) and low (0.277 s-I) shear rates using a Contraves LS30 viscometer. The samples were finally centrifuged again, the supernatant removed and its viscosity was measured on the same viscometer; since the supernatants were Newtonian, only high shear rate values were obtained. All viscometric measurements were made at 37°C. Two indices of erythrocyte aggregation were used: (1) the ratio of the low shear rate suspension viscosity to that of the supernatant, L J S ; (2) the ratio of low to high shear rate viscosities of the suspensions, Ls/L,, as recommended by the International Committee for Standardization in Haematology [22, 231. Glycosylated haemoglobin was measured by an electrophoretic technique (Corning Medical).
Results are expressed as m e a n s k~~~ or median (range). Statistical differences were determined by using Student's t-test or the Mann-Whitney U-test where appropriate. Relationships between variables were determined by Spearman's ranking method.
RESULTS
Erythrocyte glycophorin sialic acid content was decreased in the diabetic patients compared with the normal control subjects [median (range) 3.30 (0.01-11.90) versus 18.60 (3.20-32.60) pg/lOO pg of protein, P< 0.02, see Table 11 . No significant difference in glycophorin N-acetylgalactosamine or mannose contents was observed (Table 1) . Within the diabetic patients, the glycophorin sialic acid content was not influenced significantly by insulin dependence or independence, by the patients' age, by the duration of diabetes, by the presence of diabetic complications nor by the glycosylated haemoglobin level.
Erythrocyte aggregation, measured-as the ratio of suspension viscosity to supernatant viscosity (LJS) in fibrinogen solution, was increased in the diabetic patients compared with normal control subjects (mean k SEM, 37.6 -t 1. 
DISCUSSION
The sialic acid content of erythrocyte membrane glycophorin was determined by g.c.-m.s. M.s. provides a highly specific assay for individual monosaccharides. Viscometry was performed by techniques which have been described and validated previously [22, 231. Erythrocyte aggregation was determined as the ratio of the suspension viscosity to the supernatant viscosity, and as the ratio of low to high shear rate viscosity of the suspension.
Under normal circumstances erythrocytes have a negative electrical surface charge, the magnitude of which affects profoundly their interaction with other erythrocytes and with biological surfaces [24] . Glycophorin A is the major membrane glycoprotein in erythrocytes. It has 15 0-linked glycosylation sites and one N-linked site, and sialic acid and N-acetylgalactosamine are among the principal sugars in the 0-linked oligosaccharides [25] . Its sialic acid moieties are the major contributors to the negative charge on the erythrocyte membrane. In the present study the median erythrocyte glycophorin sialic acid content in normal subjects was 18.6 pg/lOO pg of protein, with values ranging from 3.2 to 32.6 pg/lOO pg of protein. A three-to four-fold range for total erythrocyte membrane sialic acid content has been described previously in normal subjects using an enzymic sialic acid assay technique with erythrocyte ghosts [lo] . The reason for this wide range of membrane sialylation in normal subjects is unknown.
The diabetes related decrease in glycophorin sialic acid content observed in the present study was specific, as levels of the other monosaccharides N-acetylgalactos- amine and mannose were not significantly affected. The mechanism of this decrease is unknown, although in other cells a diabetes-induced increase in sialidase activity [26] and decrease in sialic acid synthesis [27] have been observed. A more generalized glycosylation defect in diabetes cannot be excluded.
Decreased glycophorin sialylation was associated with an increase in erythrocyte aggregation, as would be expected if the sialic acid-induced intercellular electrostatic repulsive forces were diminished. This observation in diabetes is thought to be the first report of a defect in a specific membrane component being associated with an increase in erythrocyte aggregation. The absence of a relationship between erythrocyte sialic acid content and erythrocyte aggregation in the normal subjects may mean that, at high levels of sialylation, the inhibitory effects of sialic acid on aggregation become saturated. In diabetic patients, decreased sialylation of glycophorin, resulting in increased cell-to-cell aggregation, together with increased adhesion of erythrocytes to blood vessel walls, may be of importance in the development of the vascular disease to which they are particularly prone.
